Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000036

CEO bought 191,000 shares at an average $0.01 ($2,294)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

30 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-30 Purchase : show line 1 in the form +10,000 $0.01 $115 23,976,097 D
2019-05-30 Purchase : show line 2 in the form +1,000 $0.01 $12 23,977,097 D
2019-05-30 Purchase : show line 3 in the form +5,000 $0.01 $59 23,982,097 D
2019-05-30 Purchase : show line 4 in the form +5,000 $0.01 $57 23,987,097 D
2019-05-30 Purchase : show line 5 in the form +5,000 $0.01 $57 23,992,097 D
2019-05-30 Purchase : show line 6 in the form +5,000 $0.01 $57 23,997,097 D
2019-05-30 Purchase : show line 7 in the form +2,000 $0.01 $22 23,999,097 D
2019-05-30 Purchase : show line 8 in the form +15,000 $0.01 $176 24,014,097 D
Open-market purchases · 191,000 sh · avg $0.01 · $2,294
Loading xslF345X03/primary_doc.xml…